Negative regulation of leukocyte mediated immunity

pathway activity — cross-omics
GO:0002704Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of leukocyte mediated immunity pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ARHGAP9, ITGAL, and RASAL3, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of leukocyte mediated immunity activity versus ARHGAP9 in GBM (Pearson r = 0.69).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMARHGAP9 →+0.836+0.387<.001<.001310
CCRCCITGAL →+0.899+0.293<.001<.001310
GBMRASAL3 →+0.749+0.313<.001<.001310
GBMMYO1F →+0.894+0.335<.001<.001310
GBMWAS →+0.692+0.264<.001<.001310
CCRCCMAP4K1 →+0.744+0.283<.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002704 vs ARHGAP9 — GBM

Per-sample scatter of Negative regulation of leukocyte mediated immunity activity vs ARHGAP9 in GBM.

Explore this scatter interactively →

Exploration